Furthermore, combining VTP50469 with mezigdomide, which degrades the transcription factor Ikaros (IKZF), synergistically increases apoptosis, differentiation, and cell cycle arrest in MLLr and NPM1 mutant AML cells compared to MI alone [202,203]. This evidence concerns the gene NPM1 and acute myeloid leukemia.